Search Page
Save citations to file
Email citations
Send citations to clipboard
Add to Collections
Add to My Bibliography
Create a file for external citation management software
Your saved search
Your RSS Feed
Search Results
3 results
Filters applied: . Clear all
Results are displayed in a computed author sort order.
The Results By Year timeline is not available.
Page 1
Bispecific CD33/CD123 targeted chimeric antigen receptor T cells for the treatment of acute myeloid leukemia.
Mol Ther Oncolytics. 2023 Nov 20;31:100751. doi: 10.1016/j.omto.2023.100751. eCollection 2023 Dec 19.
Mol Ther Oncolytics. 2023.
PMID: 38075241
Free PMC article.
CD28 Costimulatory Domain-Targeted Mutations Enhance Chimeric Antigen Receptor T-cell Function.
Boucher JC, Li G, Kotani H, Cabral ML, Morrissey D, Lee SB, Spitler K, Beatty NJ, Cervantes EV, Shrestha B, Yu B, Kazi A, Wang X, Sebti SM, Davila ML.
Boucher JC, et al. Among authors: cervantes ev.
Cancer Immunol Res. 2021 Jan;9(1):62-74. doi: 10.1158/2326-6066.CIR-20-0253. Epub 2020 Nov 13.
Cancer Immunol Res. 2021.
PMID: 33188139
Free PMC article.
Item in Clipboard
4-1BB and optimized CD28 co-stimulation enhances function of human mono-specific and bi-specific third-generation CAR T cells.
Roselli E, Boucher JC, Li G, Kotani H, Spitler K, Reid K, Cervantes EV, Bulliard Y, Tu N, Lee SB, Yu B, Locke FL, Davila ML.
Roselli E, et al. Among authors: cervantes ev.
J Immunother Cancer. 2021 Oct;9(10):e003354. doi: 10.1136/jitc-2021-003354.
J Immunother Cancer. 2021.
PMID: 34706886
Free PMC article.
Item in Clipboard
Cite
Cite